GSK3335103 is an orally active, non-peptide α v β 6 integrin inhibitor ( pIC 50 =8). GSK3335103 can be used in the study of pulmonary fibrosis.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Integrin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.